Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: Towards future therapeutic application

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Frenkel, Dan ^a   Trudler, Dorit ^a   Farfara, Dorit ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR;

ALZHEIMER DISEASE; AMYLOID NEUROPATHY; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; CELLULAR IMMUNITY; DEGENERATIVE DISEASE; DISEASE MARKER; GLIA CELL; HUMAN; INNATE IMMUNITY; MICROGLIA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

AMYLOIDOSIS; ANIMALS; HUMANS; IMMUNITY, INNATE; NEURODEGENERATIVE DISEASES; NEUROGENESIS; NEUROGLIA; NEURONS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 77956802559     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/497987     Document Type: Review

References (128)

1. Janeway C. A. Jr., The immune system evolved to discriminate infectious nonself from noninfectious self Immunology Today 1992 13 1 11 16
2. Uematsu S., Akira S., The role of Toll-like receptors in immune disorders Expert Opinion on Biological Therapy 2006 6 3 203 214
3. Takeda K., Akira S., Toll-like receptors Current Protocols in Immunology 2007 chapter 14 Unit 14.12
4. Jou I., Lee J. H., Park S. Y., Yoon H. J., Joe E.-H., Park E. J., Gangliosides trigger inflammatory responses via TLR4 in brain Glia American Journal of Pathology 2006 168 5 1619 1630
5. Bsibsi M., Bajramovic J. J., Van Duijvenvoorden E., Persoon C., Ravid R., Van Noort J. M., Vogt M. H. J., Identification of soluble CD14 as an endogenous agonist for Toll-like receptor 2 on human astrocytes by genome-scale functional screening of Glial cell derived proteins Glia 2007 55 5 473 482
6. Lehnardt S., Schott E., Trimbuch T., Laubisch D., Krueger C., Wulczyn G., Nitsch R., Weber J. R., A vicious cycle involving release of heat shock protein 60 from injured cells and activation of Toll-like receptor 4 mediates neurodegeneration in the CNS Journal of Neuroscience 2008 28 10 2320 2331
7. Rock F. L., Hardiman G., Timans J. C., Kastelein R. A., Bazan J. F., A family of human receptors structurally related to Drosophila Toll Proceedings of the National Academy of Sciences of the United States of America 1998 95 2 588 593
8. Kobe B., Deisenhofer J., A structural basis of the interactions between leucine-rich repeats and protein ligands Nature 1995 374 6518 183 186
9. Xu Y., Tao X., Shen B., Horng T., Medzhitov R., Manley J. L., Tong L., Structural basis for signal transduction by the Toll/interleukin-1 receptor domains Nature 2000 408 6808 111 115
10. Verstrepen L., Bekaert T., Chau T.-L., Tavernier J., Chariot A., Beyaert R., TLR-4, IL-1R and TNF-R signaling to NF- B: variations on a common theme Cellular and Molecular Life Sciences 2008 65 19 2964 2978
11. Carty M., Goodbody R., Schrder M., Stack J., Moynagh P. N., Bowie A. G., The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling Nature Immunology 2006 7 10 1074 1081
12. Gay N. J., Keith F. J., Drosophila Toll and IL-1 receptor Nature 1991 351 6325 355 356
13. Medzhitov R., Preston-Hurlburt P., Janeway C. A. Jr., A human homologue of the Drosophila Toll protein signals activation of adaptive immunity Nature 1997 388 6640 394 397
14. Leonard J. N., Ghirlando R., Askins J., Bell J. K., Margulies D. H., Davies D. R., Segal D. M., The TLR3 signaling complex forms by cooperative receptor dimerization Proceedings of the National Academy of Sciences of the United States of America 2008 105 1 258 263
15. Liu L., Botos I., Wang Y., Leonard J. N., Shiloach J., Segal D. M., Davies D. R., Structural basis of Toll-like receptor 3 signaling with double-stranded RNA Science 2008 320 5874 379 381
16. Park B. S., Song D. H., Kim H. M., Choi B.-S., Lee H., Lee J.-O., The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex Nature 2009 458 7242 1191 1195
17. Jin M. S., Kim S. E., Heo J. Y., Lee M. E., Kim H. M., Paik S.-G., Lee H., Lee J.-O., Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide Cell 2007 130 6 1071 1082
18. Jin M. S., Lee J.-O., Structures of the Toll-like receptor family and its ligand complexes Immunity 2008 29 2 182 191
19. Hayashi F., Smith K. D., Ozinsky A., Hawn T. R., Yi E. C., Goodlett D. R., Eng J. K., Akira S., Underhill D. M., Aderem A., The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 Nature 2001 410 6832 1099 1103
20. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S., A Toll-like receptor recognizes bacterial DNA Nature 2000 408 6813 740 745
21. Ozinsky A., Underhill D. M., Fontenot J. D., Hajjar A. M., Smith K. D., Wilson C. B., Schroeder L., Aderem A., The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors Proceedings of the National Academy of Sciences of the United States of America 2000 97 25 13766 13771
22. Bulut Y., Faure E., Thomas L., Equils O., Arditi M., Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein a lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling Journal of Immunology 2001 167 2 987 994
23. Hajjar A. M., O'Mahony D. S., Ozinsky A., Underhill D. M., Aderem A., Klebanoff S. J., Wilson C. B., Cutting edge: functional interactions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin Journal of Immunology 2001 166 1 15 19
24. Bailey S. L., Carpentier P. A., McMahon E. J., Begolka W. S., Miller S. D., Innate and adaptive immune responses of the central nervous system Critical Reviews in Immunology 2006 26 2 149 188
25. McKimmie C. S., Johnson N., Fooks A. R., Fazakerley J. K., Viruses selectively upregulate Toll-like receptors in the central nervous system Biochemical and Biophysical Research Communications 2005 336 3 925 933
26. Bsibsi M., Ravid R., Gveric D., Van Noort J. M., Broad expression of Toll-like receptors in the human central nervous system Journal of Neuropathology and Experimental Neurology 2002 61 11 1013 1021
27. Zekki H., Feinstein D. L., Rivest S., The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding Toll-like receptor 2 and CD14 in the mouse CNS Brain Pathology 2002 12 3 308 319
28. Laflamme N., Soucy G., Rivest S., Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS Journal of Neurochemistry 2001 79 3 648 657
29. Kuhlmann T., Wendling U., Nolte C., Zipp F., Maruschak B., Stadelmann C., Siebert H., Brck W., Differential regulation of myelin phagocytosis by macrophages/microGlia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins Journal of Neuroscience Research 2002 67 2 185 190
30. Aldskogius H., MicroGlia in neuroregeneration Microscopy Research and Technique 2001 54 1 40 46
31. Rogers J., Lue L.-F., MicroGlial chemotaxis, activation, and phagocytosis of amyloid -peptide as linked phenomena in Alzheimer's disease Neurochemistry International 2001 39 5-6 333 340
32. Aloisi F., Ria F., Penna G., Adorini L., MicroGlia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation Journal of Immunology 1998 160 10 4671 4680
33. Block M. L., Zecca L., Hong J.-S., MicroGlia-mediated neurotoxicity: uncovering the molecular mechanisms Nature Reviews Neuroscience 2007 8 1 57 69
34. Konat G. W., Kielian T., Marriott I., The role of Toll-like receptors in CNS response to microbial challenge Journal of Neurochemistry 2006 99 1 1 12
35. Chen K., Iribarren P., Hu J., Chen J., Gong W., Cho E. H., Lockett S., Dunlop N. M., Ji M. W., Activation of Toll-like receptor 2 on microGlia promotes cell uptake of alzheimer disease-associated amyloid peptide Journal of Biological Chemistry 2006 281 6 3651 3659
36. Tahara K., Kim H.-D., Jin J.-J., Maxwell J. A., Li L., Fukuchi K.-I., Role of Toll-like receptor signalling in A uptake and clearance Brain 2006 129 11 3006 3019
37. Olson J. K., Miller S. D., MicroGlia initiate central nervous system innate and adaptive immune responses through multiple TLRs Journal of Immunology 2004 173 6 3916 3924
38. Chakravarty S., Herkenham M., Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines Journal of Neuroscience 2005 25 7 1788 1796
39. Laflamme N., Rivest S., Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components FASEB Journal 2001 15 1 155 163
40. Lehnard S., Lachance C., Patrizi S., Lefebvre S., Follett P. L., Jensen F. E., Rosenberg P. A., Volpe J. J., Vartanian T., The Toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS Journal of Neuroscience 2002 22 7 2478 2486
41. Liu Y., Walter S., Stagi M., Cherny D., Letiembre M., Schulz-Schaeffer W., Heine H., Penke B., Neumann H., Fassbender K., LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide Brain 2005 128 8 1778 1789
42. Iribarren P., Chen K., Hu J., Gong W., Cho E. H., Lockett S., Uranchimeg B., Wang J. M., CpG-containing oligodeoxynucleotide promotes microGlial cell uptake of amyloid 142 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2 FASEB Journal 2005 19 14 2032 2034
43. Doi Y., MicroGlia activated with the Toll-like receptor 9 ligand CpG attenuate oligomeric amyloid neurotoxicity in in vitro and in vivo models of Alzheimer's disease American Journal of Pathology 2009 175 5 2121 2132
44. Xie Z., Wei M., Morgan T. E., Fabrizio P., Han D., Finch C. E., Longo V. D., Peroxynitrite mediates neurotoxicity of amyloid -peptide 1-42- and lipopolysaccharide-activated microGlia Journal of Neuroscience 2002 22 9 3484 3492
45. Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., Sonobe Y., Mizuno T., Suzumura A., Tumor necrosis factor- induces neurotoxicity via glutamate release from hemichannels of activated microGlia in an autocrine manner Journal of Biological Chemistry 2006 281 30 21362 21368
46. Carpentier P. A., Begolka W. S., Olson J. K., Elhofy A., Karpus W. J., Miller S. D., Differential activation of astrocytes by innate and adaptive immune stimuli Glia 2005 49 3 360 374
47. McKimmie C. S., Fazakerley J. K., In response to pathogens, Glial cells dynamically and differentially regulate Toll-like receptor gene expression Journal of Neuroimmunology 2005 169 1-2 116 125
48. Bsibsi M., Persoon-Deen C., Verwer R. W. H., Meeuwsen S., Ravid R., Van Noort J. M., Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators Glia 2006 53 7 688 695
49. Jack C. S., Arbour N., Manusow J., Montgrain V., Blain M., McCrea E., Shapiro A., Antel J. P., TLR signaling tailors innate immune responses in human microGlia and astrocytes Journal of Immunology 2005 175 7 4320 4330
50. Suh H.-S., Zhao M.-L., Rivieccio M., Choi S., Connolly E., Zhao Y., Takikawa O., Brosnan C. F., Lee S. C., Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral response Journal of Virology 2007 81 18 9838 9850
51. Kwidzinski E., Bunse J., Kovac A. D., Ullrich O., Zipp F., Nitsch R., Bechmann I., IDO (indolamine 2,3-dioxygenase) expression and function in the CNS Advances in Experimental Medicine and Biology 2003 527 113 118
52. Lafon M., Megret F., Lafage M., Prehaud C., The innate immune facet of brain: Human neurons express TLR-3 and sense viral dsRNA Journal of Molecular Neuroscience 2006 29 3 185 194
53. Ma Y., Li J., Chiu I., Wang Y., Sloane J. A., L J., Kosaras B., Sidman R. L., Volpe J. J., Vartanian T., Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis Journal of Cell Biology 2006 175 2 209 215
54. Tang S.-C., Arumugam T. V., Xu X., Cheng A., Mughal M. R., Dong G. J., Lathia J. D., Siler D. A., Chigurupati S., Ouyang X., Magnus T., Camandola S., Mattson M. P., Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits Proceedings of the National Academy of Sciences of the United States of America 2007 104 34 13798 13803
55. Cameron J. S., Alexopoulou L., Sloane J. A., DiBernardo A. B., Ma Y., Kosaras B., Flavell R., Strittmatter S. M., Volpe J., Sidman R., Vartanian T., Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals Journal of Neuroscience 2007 27 47 13033 13041
56. Kim D., Myung A. K., Cho I.-H., Mi S. K., Lee S., Jo E.-K., Choi S.-Y., Park K., Jong S. K., Akira S., Heung S. N., Seog B. O., Sung J. L., A critical role of Toll-like receptor 2 in nerve injury-induced spinal cord Glial cell activation and pain hypersensitivity Journal of Biological Chemistry 2007 282 20 14975 14983
57. Kim Y., Zhou P., Qian L., Chuang J.-Z., Lee J., Li C., Iadecola C., Nathan C., Ding A., MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival Journal of Experimental Medicine 2007 204 9 2063 2074
58. Acosta C., Davies A., Bacterial lipopolysaccharide regulates nociceptin expression in sensory neurons Journal of Neuroscience Research 2008 86 5 1077 1086
59. Ma Y., Haynes R. L., Sidman R. L., Vartanian T., TLR8: an innate immune receptor in brain, neurons and axons Cell Cycle 2007 6 23 2859 2868
60. Prhaud C., Mgret F., Lafage M., Lafon M., Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon Journal of Virology 2005 79 20 12893 12904
61. Jackson A. C., Rossiter J. P., Lafon M., Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases Journal of NeuroVirology 2006 12 3 229 234
62. Lehnardt S., Massillon L., Follett P., Jensen F. E., Ratan R., Rosenberg P. A., Volpe J. J., Vartanian T., Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8514 8519
63. Hoffmann O., Braun J. S., Becker D., Halle A., Freyer D., Dagand E., Lehnardt S., Weber J. R., TLR2 mediates neuroinflammation and neuronal damage Journal of Immunology 2007 178 10 6476 6481
64. Lehnardt S., Henneke P., Lien E., Kasper D. L., Volpe J. J., Bechmann I., Nitsch R., Weber J. R., Golenbock D. T., Vartanian T., A mechanism for neurodegeneration induced by group B Streptococci through activation of the TLR2/MyD88 pathway in microGlia Journal of Immunology 2006 177 1 583 592
65. Bal-Price A., Brown G. C., Inflammatory neurodegeneration mediated by nitric oxide from activated Glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity Journal of Neuroscience 2001 21 17 6480 6491
66. Arimoto T., Bing G., Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microGlial activation and neurodegeneration Neurobiology of Disease 2003 12 1 35 45
67. Scumpia P. O., Kelly K. M., Reeves W. H., Stevens B. R., Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes Glia 2005 52 2 153 162
68. Melton L. M., Keith A. B., Davis S., Oakley A. E., Edwardson J. A., Morris C. M., Chronic Glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA Glia 2003 44 1 1 12
69. Castao A., Herrera A. J., Cano J., Machado A., Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system Journal of Neurochemistry 1998 70 4 1584 1592
70. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J. D., Wenk G. L., Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease Brain Research 1998 780 2 294 303
71. Monje M. L., Toda H., Palmer T. D., Inflammatory blockade restores adult hippocampal neurogenesis Science 2003 302 5651 1760 1765
72. Qin L., Wu X., Block M. L., Liu Y., Breese G. R., Hong J.-S., Knapp D. J., Crews F. T., Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration Glia 2007 55 5 453 462
73. Emsley J. G., Mitchell B. D., Kempermann G., Macklis J. D., Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells Progress in Neurobiology 2005 75 5 321 341
74. Rolls A., Shechter R., London A., Ziv Y., Ronen A., Levy R., Schwartz M., Toll-like receptors modulate adult hippocampal neurogenesis Nature Cell Biology 2007 9 9 1081 1088
75. Van Noort J. M., Toll-like receptors as targets for inflammation, development and repair in the central nervous system Current Opinion in Investigational Drugs 2007 8 1 60 65
76. Mallard C., Wang X., Hagberg H., The role of Toll-like receptors in perinatal brain injury Clinics in Perinatology 2009 36 4 763 772
77. Lathia J. D., Okun E., Tang S.-C., Griffioen K., Cheng A., Mughal M. R., Laryea G., Selvaraj P. K., Ffrench-Constant C., Magnus T., Arumugam T. V., Mattson M. P., Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation Journal of Neuroscience 2008 28 51 13978 13984
78. Braak H., Braak E., Bohl J., Staging of Alzheimer-related cortical destruction European Neurology 1993 33 6 403 408
79. Heinonen O., Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease Neuroscience 1995 64 2 375 384
80. Jellinger K. A., Bancher C., AD neuropathology Neurology 1996 46 4 1186 1187
81. Farfara D., Lifshitz V., Frenkel D., Neuroprotective and neurotoxic properties of Glial cells in the pathogenesis of Alzheimer's disease Journal of Cellular and Molecular Medicine 2008 12 3 762 780
82. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G. M., Cooper N. R., Eikelenboom P., Emmerling M., Fiebich B. L., Finch C. E., Frautschy S., Griffin W. S. T., Hampel H., Hull M., Landreth G., Lue L.-F., Mrak R., MacKenzie I. R., McGeer P. L., O'Banion M. K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F. L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T., Inflammation and Alzheimer's disease Neurobiology of Aging 2000 21 3 383 421
83. Letiembre M., Liu Y., Walter S., Hao W., Pfander T., Wrede A., Schulz-Schaeffer W., Fassbender K., Screening of innate immune receptors in neurodegenerative diseases: a similar pattern Neurobiology of Aging 2009 30 5 759 768
84. Fassbender K., Walter S., Khl S., Landmann R., Ishii K., Bertsch T., Stalder A. K., Muehlhauser F., Liu Y., Ulmer A. J., Rivest S., Lentschat A., Gulbins E., Jucker M., Staufenbiel M., Brechtel K., Walter J., Multhaup G., Penke B., Adachi Y., Hartmann T., Beyreuther K., The LPS receptor (CD14) links innate immunity with Alzheimer's disease The FASEB Journal 2004 18 1 203 205
85. Letiembre M., Hao W., Liu Y., Walter S., Mihaljevic I., Rivest S., Hartmann T., Fassbender K., Innate immune receptor expression in normal brain aging Neuroscience 2007 146 1 248 254
86. Walter S., Letiembre M., Liu Y., Heine H., Penke B., Hao W., Bode B., Manietta N., Walter J., Schulz-Schffer W., Fabender K., Role of the Toll-like receptor 4 in neuroinflammation in Alzheimer's disease Cellular Physiology and Biochemistry 2007 20 6 947 956
87. Frank S., Copanaki E., Burbach G. J., Mller U. C., Deller T., Differential regulation of Toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice Neuroscience Letters 2009 453 1 41 44
88. Richard K. L., Filali M., Prfontaine P., Rivest S., Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid 142 and delay the cognitive decline in a mouse model of Alzheimer's disease Journal of Neuroscience 2008 28 22 5784 5793
89. Minoretti P., Gazzaruso C., Vito C. D., Emanuele E., Bianchi M., Coen E., Reino M., Geroldi D., Effect of the functional Toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease Neuroscience Letters 2006 391 3 147 149
90. Fiala M., Liu P. T., Espinosa-Jeffrey A., Rosenthal M. J., Bernard G., Ringman J. M., Sayre J., Zhang L., Zaghi J., Dejbakhsh S., Chiang B., Hui J., Mahanian M., Baghaee A., Hong P., Cashman J., Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin Proceedings of the National Academy of Sciences of the United States of America 2007 104 31 12849 12854
91. Balistreri C. R., Colonna-Romano G., Lio D., Candore G., Caruso C., TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases Journal of Clinical Immunology 2009 29 4 406 415
92. Ferwerda B., McCall M. B. B., Verheijen K., Kullberg B.-J., Van Der Ven A. J. A. M., Van Der Meer J. W. M., Netea M. G., Functional consequences of Toll-like receptor 4 polymorphisms Molecular Medicine 2008 14 5-6 346 352
93. Lotz M., Ebert S., Esselmann H., Iliev A. I., Prinz M., Wiazewicz N., Wiltfang J., Gerber J., Nau R., Amyloid beta peptide 140 enhances the action of Toll-like receptor-2 and -4 agonists but antagonizes Toll-like receptor-9-induced inflammation in primary mouse microGlial cell cultures Journal of Neurochemistry 2005 94 2 289 298
94. Bamberger M. E., Harris M. E., McDonald D. R., Husemann J., Landreth G. E., A cell surface receptor complex for fibrillar -amyloid mediates microGlial activation Journal of Neuroscience 2003 23 7 2665 2674
95. Reed-Geaghan E. G., Savage J. C., Hise A. G., Landreth G. E., CD14 and Toll-like receptors 2 and 4 are required for fibrillar A -stimulated microGlial activation Journal of Neuroscience 2009 29 38 11982 11992
96. DiCarlo G., Wilcock D., Henderson D., Gordon M., Morgan D., Intrahippocampal LPS injections reduce A load in APP+PS1 transgenic mice Neurobiology of Aging 2001 22 6 1007 1012
97. Cashman J. R., Ghirmai S., Abel K. J., Fiala M., Immune defects in Alzheimer's disease: new medications development BMC Neuroscience 2008 9 supplement 2, article no. S13
98. Frenkel D., Puckett L., Petrovic S., Xia W., Chen G., Vega J., Dembinsky-Vaknin A., Shen J., Plante M., Burt D. S., Weiner H. L., A nasal proteosome adjuvant activates microGlia and prevents amyloid deposition Annals of Neurology 2008 63 5 591 601
99. Aguzzi A., Baumann F., Bremer J., The prion's elusive reason for being Annual Review of Neuroscience 2008 31 439 477
100. Aguzzi A., Sigurdson C., Heikenwaelder M., Molecular mechanisms of prion pathogenesis Annual Review of Pathology 2008 3 11 40
101. McBride S. M., Prion protein: a pattern recognition receptor for viral components and uric acid responsible for the induction of innate and adaptive immunity Medical Hypotheses 2005 65 3 570 577
102. Spinner D. S., In S. C., Seung Y. P., Jae I. K., Meeker H. C., Ye X., LaFauci G., Kerr D. J., Flory M. J., Bo S. K., Kascsak R. B., Wisniewski T., Levis W. R., Schuller-Levis G. B., Carp R. I., Park E., Kascsak R. J., Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice Journal of Virology 2008 82 21 10701 10708
103. Stoeck K., Bodemer M., Ciesielczyk B., Meissner B., Bartl M., Heinemann U., Zerr I., Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Archives of Neurology 2005 62 10 1591 1594 (Pubitemid 41434566)
104. Boonstra A., Rajsbaum R., Holman M., Marques R., Asselin-Paturel C., Pereira J. P., Bates E. E. M., Akira S., Vieira P., Liu Y.-J., Trinchieri G., O'Garra A., Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals Journal of Immunology 2006 177 11 7551 7558
105. Aguzzi A., Heikenwalder M., Pathogenesis of prion diseases: current status and future outlook Nature Reviews Microbiology 2006 4 10 765 775
106. Prinz M., Heikenwalder M., Schwarz P., Takeda K., Akira S., Aguzzi A., Prion pathogenesis in the absence of Toll-like receptor signalling EMBO Reports 2003 4 2 195 199 (Pubitemid 36322162)
107. Sethi S., Lipford G., Wagner H., Kretzschmar H., Postexposure prophylaxis against prion disease with a stimulator of innate immunity Lancet 2002 360 9328 229 230
108. Beringue V., Demoy M., Lasmzas C. I., Gouritin B., Weingarten C., Deslys J.-P., Andreux J.-P., Couvreur P., Dormont D., Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis Journal of Pathology 2000 190 4 495 502
109. Lomen-Hoerth C., Amyotrophic lateral sclerosis from bench to bedside Seminars in Neurology 2008 28 2 205 211
110. Gurney M. E., Liu R., Althaus J. S., Hall E. D., Becker D. A., Mutant CuZn superoxide dismutase in motor neuron disease Journal of Inherited Metabolic Disease 1998 21 5 587 597 (Pubitemid 28391510)
111. Reaume A. G., Elliott J. L., Hoffman E. K., Kowall N. W., Ferrante R. J., Siwek D. F., Wilcox H. M., Flood D. G., Beal M. F., Brown R. H. Jr., Scott R. W., Snider W. D., Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury Nature Genetics 1996 13 1 43 47
112. Lobsiger C. S., Cleveland D. W., Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease Nature Neuroscience 2007 10 11 1355 1360
113. Banci L., Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS Proceedings of the National Academy of Sciences of the United States of America 2007 104 27 11263 11267
114. Beers D. R., Henkel J. S., Xiao Q., Zhao W., Wang J., Yen A. A., Siklos L., McKercher S. R., Appel S. H., Wild-type microGlia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis Proceedings of the National Academy of Sciences of the United States of America 2006 103 43 16021 16026
115. Kang J., Rivest S., MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis Journal of Cell Biology 2007 179 6 1219 1230
116. Zhao W., Extracellular mutant SOD1 induces microglial-mediated motorneuron injury Glia 2009 58 231 243
117. Nguyen M. D., D'Aigle T., Gowing G., Julien J.-P., Rivest S., Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis Journal of Neuroscience 2004 24 6 1340 1349
118. Mayeux R., Epidemiology of neurodegeneration Annual Review of Neuroscience 2003 26 81 104
119. Fahn S., Clarence-Smith K. E., Chase T. N., Parkinson's disease: neurodegenerative mechanisms and neuroprotective interventionsreport of a workshop Movement Disorders 1998 13 5 759 767
120. Thomas B., Parkinson's disease: from molecular pathways in disease to therapeutic approaches Antioxidants and Redox Signaling 2009 11 9 2077 2082
121. Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M., Goedert M., -Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies Proceedings of the National Academy of Sciences of the United States of America 1998 95 11 6469 6473 (Pubitemid 28249037)
122. Croisier E., Moran L. B., Dexter D. T., Pearce R. K. B., Graeber M. B., MicroGlial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition Journal of Neuroinflammation 2005 2, article no. 14
123. Dutta G., Zhang P., Liu B., The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery Fundamental and Clinical Pharmacology 2008 22 5 453 464
124. Arai H., Furuya T., Yasuda T., Miura M., Mizuno Y., Mochizuki H., Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microGlial activation, interleukin-1, and expression of caspase-11 in mice Journal of Biological Chemistry 2004 279 49 51647 51653
125. Liu B., Jiang J.-W., Wilson B. C., Du L., Yang S.-N., Wang J.-Y., Wu G.-C., Cao X.-D., Hong J.-S., Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide Journal of Pharmacology and Experimental Therapeutics 2000 295 1 125 132
126. Panaro M. A., Lofrumento D. D., Saponaro C., De Nuccio F., Cianciulli A., Mitolo V., Nicolardi G., Expression of TLR4 and CD14 in the central nervous system (CNS) in a MPTP mouse model of Parkinson's-like disease Immunopharmacology and Immunotoxicology 2008 30 4 729 740
127. Masliah E., Rockenstein E., Adame A., Alford M., Crews L., Hashimoto M., Seubert P., Lee M., Goldstein J., Chilcote T., Games D., Schenk D., Effects of -synuclein immunization in a mouse model of Parkinson's disease Neuron 2005 46 6 857 868
128. Kanzler H., Barrat F. J., Hessel E. M., Coffman R. L., Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists Nature Medicine 2007 13 5 552 559